On March 27, 2023, Everest Medicines Limited closed the transaction. The company has received $280 million in the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.05 HKD | 0.00% | -1.64% | +15.07% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.07% | 983M | |
-2.35% | 89.33B | |
+4.08% | 41.19B | |
-14.85% | 31.87B | |
+53.68% | 24.52B | |
-14.35% | 15.68B | |
-8.63% | 12.34B | |
-40.39% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B |
- Stock Market
- Equities
- 1952 Stock
- News Everest Medicines Limited
- Everest Medicines Limited announced that it has received $280 million in funding from Immunomedics, Inc.